Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis-Reference-Cited by-同舟云学术

Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis

Published:2021-10 Issue:1 Volume:163 Page:162-170
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

D'Amora Paulo,Silva Ismael Dale C.G.,Tewari Krishnansu S.,Bristow Robert E.,Cappuccini Fabio,Evans Steven S.,Salzgeber Marcia B.,Addis-Bernard Paula J.,Palma Anton M.,Marchioni Dirce M.L.,Carioca Antonio A.F.,Penner Kristine R.,Alldredge Jill,Longoria Teresa,Nagourney Robert A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. The prevalence and associated factors for liver metastases, development and prognosis in newly diagnosed epithelial ovarian cancer: a large population-based study from the SEER database;Hussain;J. Cancer,2020

2. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J. Clin. Oncol.,2002

3. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival;Memarzadeh;Int. J. Gynecol. Cancer,2002

4. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med.,1996

5. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study;Sovak;Int. J. Gynecol. Cancer,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry;Metabolites;2024-02-29

2. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

3. Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics;Cancer Cell International;2023-12-06

4. Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants;Genes;2023-03-19

5. Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1;Cancers;2023-01-31